PIPERACILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Piperacillin patents expire, and what generic alternatives are available?
Piperacillin is a drug marketed by Istituto Bio Ita Spa, Astral, Eugia Pharma, Eugia Pharma Speclts, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Provepharm Sas, Sagent Pharms Inc, Sandoz, Shandong, Steriscience, and Wockhardt Bio Ag. and is included in twenty-four NDAs.
The generic ingredient in PIPERACILLIN is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIPERACILLIN?
- What are the global sales for PIPERACILLIN?
- What is Average Wholesale Price for PIPERACILLIN?
Summary for PIPERACILLIN
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 24 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 99 |
Patent Applications: | 4,647 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PIPERACILLIN |
DailyMed Link: | PIPERACILLIN at DailyMed |
![PIPERACILLIN drug patent expirations Drug patent expirations by year for PIPERACILLIN](/p/graph/s/t/PIPERACILLIN-patent-expirations.png)
![Drug Prices for PIPERACILLIN](/p/graph/drug-price/PIPERACILLIN.png)
Recent Clinical Trials for PIPERACILLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wake Forest University Health Sciences | Phase 4 |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 |
Rutgers, The State University of New Jersey | Phase 3 |
US Patents and Regulatory Information for PIPERACILLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 203557-001 | Oct 29, 2014 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sagent Pharms Inc | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 208674-002 | Feb 16, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Steriscience | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 065458-003 | Aug 15, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |